Rita M O'Connor, Dipexium Pharmaceuticals, Inc.'s Chief Financial Officer, has now declared ownership of 60,000 options from the company. The strike price of the options received was $6.28, and these expire on July 01, 2027.
Some additional info was provided as follows:
The option will become exercisable as to 20,000 shares (subject to continued employment through such date) on each of July 1, 2018, July 1, 2019, and July 1, 2020.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
General statement of acquisition of beneficial ownership - Nov. 20, 2017
Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Nov. 9, 2017
Departure of Directors or Certain - Oct. 27, 2017